CAN LARGE LANGUAGE MODELS SIMULATE HTA COMMITTEE DISCUSSIONS? FINDINGS AND CHALLENGES FROM A CASE STUDY IN NEOADJUVANT TREATMENT OF RESECTABLE NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Reason, T. [1 ]
Klijn, S. [2 ]
Gimblett, A. [1 ]
Malcolm, B. [3 ]
机构：
[1] Estima Sci Ltd, London, England
[2] Bristol Myers Squibb, Utrecht, ZH, Netherlands
[3] Bristol Myers Squibb, London, Middx, England
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P46
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer. A Narrative Review
    Gatteschi, Lavinia
    Iannopollo, Mauro
    Gonfiotti, Alessandro
    LIFE-BASEL, 2021, 11 (10):
  • [32] Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better?
    Ulas, Ezgi B.
    Bahce, Idris
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (07) : 1369 - 1371
  • [33] Phase II study of Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer
    Ramnath, N
    Sommers, E
    Robinson, L
    Nwogu, C
    Sharma, A
    Cantor, A
    Bepler, G
    CHEST, 2005, 128 (05) : 3467 - 3474
  • [34] Neoadjuvant chemoimmunotherapy in resectable stage IIIA/IIIB non-small cell lung cancer
    Chen, Yulong
    Yan, Bo
    Xu, Feng
    Hui, Zhenzhen
    Zhao, Gang
    Liu, Jie
    Zhang, Huan
    Zeng, Ziqing
    Zhang, Ran
    Provencio, Mariano
    Ren, Xiubao
    You, Jian
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (05) : 2193 - +
  • [35] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    LUNG CANCER, 2023, 183
  • [36] Neoadjuvant atezolizumab plus chemotherapy in resectable non-small cell lung cancer (NSCLC).
    Shu, Catherine A.
    Grigg, Claud
    Chiuzan, Codruta
    Garofano, Robert F.
    Patel, Vijeta
    Hernandez, Susana
    Negri, Tiffany
    Sacher, Adrian G.
    Smith-Marrone, Stephanie
    Stoopler, Mark
    Gainor, Justin F.
    Awad, Mark M.
    D'Ovidio, Frank
    Sonett, Joshua R.
    Bacchetta, Matthew
    Saqi, Anjali
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non-Small Cell Lung Cancer
    Schuler, Martin
    CLINICAL CANCER RESEARCH, 2025, 31 (05) : 801 - 807
  • [38] Treatment of resectable stage IIIA non-small cell lung cancer
    Cardenal, Felipe
    Palmero, Ramon
    JOURNAL OF THORACIC DISEASE, 2017, 9 (01) : 13 - 15
  • [39] Neoadjuvant immuno-chemotherapy in resectable non-small cell lung cancer: A retrospective cohort study
    Verma, Saurav
    Vincent, Mark David
    Black, Morgan
    Nayak, Rahul
    Cecchini, Matthew
    Malthaner, Richard
    Raphael, Jacques
    Inculet, Richard
    Fortin, Dalilah
    Blanchette, Philip
    Kuruvilla, Sara
    Qiabi, Mehdi
    Younus, Jawaid
    Breadner, Daniel Adam
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] Role of Neoadjuvant Immune Checkpoint Inhibitors in Resectable Non-Small Cell Lung Cancer
    Riano, Ivy
    Abuali, Inas
    Sharma, Aditya
    Durant, Jewelia
    Dragnev, Konstantin H. H.
    PHARMACEUTICALS, 2023, 16 (02)
12345